Filed: 2/14/2023ACC: 0001420506-23-000502
📋 What this filing means
GHOST TREE CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $234.22M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$234.22M
Total AUM (reported)
11.38M
Total Shares
Allocation by class
COM$186.03M79.4%
CL A$19.00M8.1%
SPONSORED ADR$15.88M6.8%
UNIT SER 1$13.31M5.7%
Portfolio Concentration
Top 3$53.00M22.6%
4–10$82.69M35.3%
11–25$84.95M36.3%
Rest$13.58M5.8%
Top 3 weight
22.6%
Top 10 weight
57.9%
Voting Authority Distribution
Total shares with voting rights: 11.38M
Sole
Full voting authority
11.38M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
REATA PHARMACEUTICALS INC
SOLEShares500K
TypeSH
Market value$19.00M
8.11%
Sole
500K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares235K
TypeSH
Market value$18.13M
7.74%
Sole
235K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares130K
TypeSH
Market value$15.88M
6.78%
Sole
130K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares300K
TypeSH
Market value$15.51M
6.62%
Sole
300K
Shared
0.00
None
0.00
INVESCO QQQ TR
SOLEShares50K
TypeSH
Market value$13.31M
5.68%
Sole
50K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares350K
TypeSH
Market value$12.93M
5.52%
Sole
350K
Shared
0.00
None
0.00
CTI BIOPHARMA CORP
SOLEShares1.85M
TypeSH
Market value$11.12M
4.75%
Sole
1.85M
Shared
0.00
None
0.00
SEAGEN INC
SOLEShares85K
TypeSH
Market value$10.92M
4.66%
Sole
85K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares450K
TypeSH
Market value$9.63M
4.11%
Sole
450K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares800K
TypeSH
Market value$9.25M
3.95%
Sole
800K
Shared
0.00
None
0.00
MIRATI THERAPEUTICS INC
SOLEShares200K
TypeSH
Market value$9.06M
3.87%
Sole
200K
Shared
0.00
None
0.00
IOVANCE BIOTHERAPEUTICS INC
SOLEShares1.30M
TypeSH
Market value$8.31M
3.55%
Sole
1.30M
Shared
0.00
None
0.00
KARUNA THERAPEUTICS INC
SOLEShares40K
TypeSH
Market value$7.86M
3.36%
Sole
40K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares160K
TypeSH
Market value$7.67M
3.28%
Sole
160K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares55K
TypeSH
Market value$7.13M
3.04%
Sole
55K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares450K
TypeSH
Market value$6.70M
2.86%
Sole
450K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares20K
TypeSH
Market value$5.80M
2.48%
Sole
20K
Shared
0.00
None
0.00
REVANCE THERAPEUTICS INC
SOLEShares300K
TypeSH
Market value$5.54M
2.36%
Sole
300K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares165K
TypeSH
Market value$4.82M
2.06%
Sole
165K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares85K
TypeSH
Market value$4.66M
1.99%
Sole
85K
Shared
0.00
None
0.00
PROVENTION BIO INC
SOLEShares400K
TypeSH
Market value$4.23M
1.81%
Sole
400K
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares135K
TypeSH
Market value$3.96M
1.69%
Sole
135K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares150K
TypeSH
Market value$3.82M
1.63%
Sole
150K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares300K
TypeSH
Market value$2.82M
1.20%
Sole
300K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares225K
TypeSH
Market value$2.58M
1.10%
Sole
225K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REATA PHARMACEUTICALS INCSOLE | CL A | 500K | SH | $19.00M 8.11% | 500K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 235K | SH | $18.13M 7.74% | 235K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 130K | SH | $15.88M 6.78% | 130K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 300K | SH | $15.51M 6.62% | 300K | 0.00 | 0.00 |
INVESCO QQQ TRSOLE | UNIT SER 1 | 50K | SH | $13.31M 5.68% | 50K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 350K | SH | $12.93M 5.52% | 350K | 0.00 | 0.00 |
CTI BIOPHARMA CORPSOLE | COM | 1.85M | SH | $11.12M 4.75% | 1.85M | 0.00 | 0.00 |
SEAGEN INCSOLE | COM | 85K | SH | $10.92M 4.66% | 85K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 450K | SH | $9.63M 4.11% | 450K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 800K | SH | $9.25M 3.95% | 800K | 0.00 | 0.00 |
MIRATI THERAPEUTICS INCSOLE | COM | 200K | SH | $9.06M 3.87% | 200K | 0.00 | 0.00 |
IOVANCE BIOTHERAPEUTICS INCSOLE | COM | 1.30M | SH | $8.31M 3.55% | 1.30M | 0.00 | 0.00 |
KARUNA THERAPEUTICS INCSOLE | COM | 40K | SH | $7.86M 3.36% | 40K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 160K | SH | $7.67M 3.28% | 160K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 55K | SH | $7.13M 3.04% | 55K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 450K | SH | $6.70M 2.86% | 450K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 20K | SH | $5.80M 2.48% | 20K | 0.00 | 0.00 |
REVANCE THERAPEUTICS INCSOLE | COM | 300K | SH | $5.54M 2.36% | 300K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 165K | SH | $4.82M 2.06% | 165K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 85K | SH | $4.66M 1.99% | 85K | 0.00 | 0.00 |
PROVENTION BIO INCSOLE | COM | 400K | SH | $4.23M 1.81% | 400K | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COM | 135K | SH | $3.96M 1.69% | 135K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 150K | SH | $3.82M 1.63% | 150K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 300K | SH | $2.82M 1.20% | 300K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 225K | SH | $2.58M 1.10% | 225K | 0.00 | 0.00 |
Page 1 of 2